Cerimon Pharmaceuticals, Inc. — Form D/A
Cerimon Pharmaceuticals, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D amendment with the SEC on 2010-06-24. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2010-06-24
- Form: D/A
- Accession: 0001329473-10-000002
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 10
- Date of first sale: 2010-03-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-77816
Issuer
- Name: Cerimon Pharmaceuticals, Inc.
- CIK: 0001329473
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2004
- Address: 701 GATEWAY BLVD., #100, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650 827-4000
Officers, directors & promoters (17)
| Name | Role | Location |
|---|
| James S Shannon | Director | West Lafayette, IN |
| Gary P Patou | Executive Officer | South San Francisco, CA |
| James H Welch | Executive Officer | Palo Alto, CA |
| Gary Patou | Executive Officer | South San Francisco, CA |
| Ansbert Gadicke | Director | Morristown, NJ |
| Robert Adelman | Director | San Francisco, CA |
| Paul Hastings | Director | South San Francisco, CA |
| Samuel P Wertheimer | Director | New York, NY |
| Vaughn Kailian | Director | Chapel Hill, NC |
| James S Shannon | Executive Officer | West Lafayette, IN |
| Denise P Pollard-Knight | Director | South San Francisco, CA |
| James P Shannon | Director | South San Francisco, CA |
| Ansbert P Gadicke | Director | South San Francisco, CA |
| Paul P Hastings | Director | South San Francisco, CA |
| Matthew J Meyer | Executive Officer | South San Francisco, CA |
| Vaughn P Kailian | Director | South San Francisco, CA |
| Denise Pollard-Knight | Director | South San Francisco, CA |
Other filings by this issuer (4)
More